- Home
- Publications
- Publication Search
- Publication Details
Title
Edoxaban
Authors
Keywords
-
Journal
DRUGS
Volume 71, Issue 12, Pages 1503-1526
Publisher
Springer Nature
Online
2011-10-05
DOI
10.2165/11595540-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome
- (2011) C. Michael Gibson et al. AMERICAN HEART JOURNAL
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study
- (2010) AMERICAN HEART JOURNAL
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
- Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment
- (2010) John W. Eikelboom et al. AMERICAN HEART JOURNAL
- Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale
- (2010) Renato D. Lopes et al. AMERICAN HEART JOURNAL
- 2010 Clinical Trial/Clinical Science Abstracts
- (2010) CIRCULATION
- Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation
- (2010) Jonathan P Piccini et al. CURRENT OPINION IN CARDIOLOGY
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPACE
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Drug and dietary interactions of the new and emerging oral anticoagulants
- (2010) J. M. Walenga et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers
- (2010) Koichiro Ogata et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Food on the Pharmacokinetics of Edoxaban, an Oral Direct Factor Xa Inhibitor, in Healthy Volunteers
- (2010) Jeanne Mendell et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty
- (2010) T. FUJI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
- (2010) Michael Rud Lassen et al. LANCET
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism
- (2010) Thomas Mavrakanas et al. PHARMACOLOGY & THERAPEUTICS
- Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation
- (2010) Stuart Connolly et al. THROMBOSIS AND HAEMOSTASIS
- Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement
- (2010) Alexander Cohen et al. THROMBOSIS AND HAEMOSTASIS
- New oral anticoagulant drugs in cardiovascular disease
- (2010) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- Treatments for stroke prevention in atrial fibrillation: A network meta-analysis and indirect comparisons versus dabigatran etexilate
- (2010) Gregory Y. H. Lip et al. THROMBOSIS AND HAEMOSTASIS
- Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation
- (2010) Hui-Kyung Jeon et al. THROMBOSIS AND HAEMOSTASIS
- Increasing Prevalence of Atrial Fibrillation and Flutter in the United States
- (2009) Gerald V. Naccarelli et al. AMERICAN JOURNAL OF CARDIOLOGY
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
- (2009) Alexander GG Turpie et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement
- (2009) Michael Rud Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study
- (2008) H. R. Buller et al. BLOOD
- Treatment of atrial fibrillation
- (2008) Abhay Bajpai et al. BRITISH MEDICAL BULLETIN
- Antithrombotic Therapy for Venous Thromboembolic Disease
- (2008) Clive Kearon et al. CHEST
- Prevention of Venous Thromboembolism
- (2008) William H. Geerts et al. CHEST
- Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
- (2008) Stuart J. Connolly et al. CIRCULATION
- Update on Atrial Fibrillation: Part I
- (2008) Irina Savelieva et al. CLINICAL CARDIOLOGY
- Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
- (2008) Bengt I Eriksson et al. CLINICAL PHARMACOKINETICS
- Guidelines on the diagnosis and management of acute pulmonary embolism
- (2008) et al. EUROPEAN HEART JOURNAL
- Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
- (2008) Ajay K Kakkar et al. LANCET
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
- (2008) Bengt I. Eriksson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
- (2008) Michael R. Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started